Saliva Collection and Diagnostics Market Size & Share 2024 to 2032

Saliva Collection and Diagnostics Market Size

Saliva Collection and Diagnostics Market size was valued at USD 1.4 billion in 2023 and is anticipated to witness growth at a CAGR of 8.3% between 2024 and 2032, fueled by the rising incidence of chronic diseases, a shift towards minimally invasive diagnostic techniques, and increased investment in research and development.

Technological advances and the growing preference for non-blood diagnostic methods are driving this evolution. Furthermore, the market benefits from frequent product approvals and launches, such as Spectrum Solutions' recent introduction of SimplyPERIO in March 2024. This advanced saliva diagnostics device can detect 16 oral targets from a single saliva sample, highlighting the market's innovation and growth prospects.
 

Ongoing research and development in the saliva collection and diagnostics market are driving innovations in diagnostic methods. Saliva, rich in biomarkers like hormones, antibodies, and genetic material, offers valuable insights into health conditions such as infectious diseases, hormonal imbalances, and oral health issues. Its non-invasive, easy-to-collect nature makes saliva an attractive alternative to traditional blood or urine samples for both patients and healthcare providers, providing a convenient and effective diagnostic option. 
 

The market involve the collection, analysis, and interpretation of saliva samples for medical and research purposes. It includes the use of saliva for diagnosing diseases, monitoring health conditions, conducting biomedical research, and facilitating non-invasive drug testing. This market caters to healthcare providers, research institutions, and biotechnology companies, leveraging advancements in technology to enhance the accuracy and efficiency of diagnostic procedures and personalized medicine approaches.
 

Saliva Collection and Diagnostics Market Trends

• The growth of market is attributed to technological advancements, shifting healthcare paradigms, and emerging applications in both clinical and research settings.
   
• There is a considerable shift in the adoption of point-of-care (POC) testing solutions. POC testing allows for rapid, on-site analysis of saliva samples, eliminating the need for sample transportation to centralized laboratories and enabling real-time decision-making by healthcare providers.
   
• This trend is particularly relevant in settings where immediate diagnostic information is critical, such as emergency departments, primary care clinics, and remote or resource-limited areas.
   
• As technology continues to improve, POC saliva testing devices are becoming more accurate, user-friendly, and cost-effective, driving their widespread adoption across various healthcare settings. For instance, in June 2023, Abingdon Health plc launched saliva-based pregnancy kit called Salistick. The company launched this product in UK and Ireland.
   
• Furthermore, growing interest in personalized medicine and precision diagnostics. Saliva-based biomarkers offer valuable insights into an individual's unique physiological characteristics, allowing for personalized treatment strategies tailored to each patient's specific needs. For instance, in September 2023, Conceptomed announced launch of its new SalivaPOD device for collection of human saliva for genetic and personalized testing.
   
• Advances in genomic and proteomic technologies have expanded the repertoire of saliva biomarkers that can be analyzed, enabling the development of targeted diagnostic tests for a wide range of health conditions, including cancer, cardiovascular disease, and neurodegenerative disorders. As our understanding of the molecular basis of disease continues to evolve, saliva-based diagnostics are poised to play a central role in the era of precision medicine.
   

Saliva Collection and Diagnostics Market Analysis

Based on site of collection, the market is segmented into parotid gland collection, submandibular/sublingual gland collection, and minor salivary gland. The submandibular/sublingual gland segment held a dominant market share of 49.0% in 2023.
 

• The increasing adoption of submandibular/sublingual gland site of saliva collection and analysis represents a significant trend in the field of saliva-based diagnostics. The segment growth is driven by several factors, including the unique composition of saliva from these glands, the ease of sample collection, and the growing recognition of the clinical relevance of submandibular/sublingual saliva biomarkers.
   
• Saliva collected from the submandibular/sublingual glands differs in composition from whole saliva or saliva collected from other sites in the oral cavity. These glands secrete a higher proportion of mucin-rich saliva, which contains a diverse array of biomolecules, including proteins, hormones, antibodies, and nucleic acids. This characteristic of submandibular gland is responsible for the considerable segment share.  
   
• Furthermore, the clinical relevance of submandibular/sublingual saliva biomarkers is increasingly being recognized across various medical specialties. Studies have shown that biomarkers present in submandibular/sublingual saliva can provide valuable insights into the pathophysiology of systemic diseases, oral health conditions, and neurological disorders.
   

Based on application, the saliva collection and diagnostics market is classified disease diagnostics, forensics, and research. Disease diagnostics segment is further categorized into infectious diseases, genetic testing, and others. The disease diagnostics segment accounted for the highest market share and was valued at USD 696.9 million in 2023.
 

• Saliva samples play a crucial role in disease diagnostics due to their unique composition and non-invasive collection method, offering significant advantages over traditional diagnostic techniques. Saliva contains a diverse array of biomolecules, including proteins, hormones, antibodies, enzymes, nucleic acids, and microorganisms, which can serve as indicators of various health conditions.
   
• One of the key advantages of saliva samples in disease diagnostics is the ease and convenience of collection. Unlike blood or tissue samples that require invasive procedures for collection, saliva can be obtained non-invasively through simple and painless methods such as passive drool, saliva collection devices, or oral swabs.
   
• The minimally invasive nature of saliva sampling makes it particularly attractive for vulnerable populations, including children, the elderly, and individuals with needle phobia, as well as in resource-limited settings where healthcare access is limited. Industrial developments by market players are also driving segment growth. For instance, in December 2023, Molbio Diagnostics partnered with Testi Technologies to commercialize self-test saliva kits designed to detect alcohol content using salivary enzymes, highlighting the market's innovative and expanding applications.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the saliva collection and diagnostics market is categorized into hospitals and dental clinics, diagnostic laboratories, pharmaceutical & biotechnology companies, research institutes, and forensic laboratories. The diagnostic laboratories segment is projected to reach USD 948.2 million by 2032.
 

• Diagnostic centers play an important role in saliva testing by serving as the primary facilities for sample analysis, result interpretation, and patient management. These centers are equipped with state-of-the-art laboratory infrastructure, including specialized equipment and skilled personnel, to perform a wide range of saliva-based diagnostic tests with high accuracy and precision.
   
• Moreover, diagnostic centers provide the expertise and resources needed to process saliva samples efficiently and accurately. Further, healthcare authorities are focusing on providing convenient services to the patients, which is estimated leverage segment growth by 2032. For instance, in April 2023, Yale Pathology Labs introduced state-of-the art mobile pathology lab to reach out to underserved communities.

North America saliva collection and diagnostics market size in 2023 was valued at USD 572.5 million and is predicted to grow at a CAGR of 7.8% over the analysis timeframe.
 

• The adoption of saliva testing is increasing in North America due to increasing demand for non-invasive and scalable diagnostic solutions.
   
• Advancements in technology and research have improved the accuracy, sensitivity, and reliability of saliva-based diagnostic tests. Innovations in molecular diagnostics, proteomics, and genomics have expanded the repertoire of saliva biomarkers that can be analyzed, enabling the development of tests for a wide range of infectious diseases, autoimmune disorders, cancer, and other health conditions.
   

U.S. saliva collection and diagnostics market is anticipated to grow at a CAGR of 7.7% to reach USD 1.0 billion by the end of the forecast timeframe.
 

• Saliva offers a convenient and non-invasive alternative to traditional diagnostic samples such as blood or tissue, making it more accessible and acceptable to patients of all ages and health statuses. In addition, continual research and innovation activities by researchers are also likely to propel U.S. market during the forecast period.
   

UK saliva collection and diagnostics market is projected to grow remarkably in the coming years.
 

• Advancements in technology and research have improved the reliability and accuracy of saliva-based diagnostic tests. Innovations in molecular biology, proteomics, and genomics have expanded the range of biomarkers that can be detected in saliva, enabling the development of tests for various infectious diseases, autoimmune disorders, cancer, and other health conditions.
   
• Furthermore, the growing recognition of saliva as a valuable diagnostic medium among healthcare professionals and the general public has contributed to the increasing adoption of saliva testing in the UK. For instance, a new self-test saliva kit is being developed by researchers in the UK which will be utilized as a part of prostate cancer diagnostics. The research is being funded by Biomedical Research Centre and National Institute for Health and Care Research amongst others.  
   

China is experiencing high market growth in the saliva collection and diagnostics market.
 

• The growth of China market is attributed to technological advancements, demand for effective and painless diagnostic procedures, and launch of new products.
   
• Furthermore, the cultural acceptance of saliva as a diagnostic medium in China has contributed to its widespread adoption. Traditional Chinese medicine has long recognized the diagnostic value of saliva in assessing an individual's health status, and this cultural acceptance has facilitated the integration of saliva testing into mainstream healthcare services in China.
   

Saliva Collection and Diagnostics Market Share

The market industry is characterized by the presence of several established and emerging players that offer a variety of treatments across the globe. The market players compete based on factors such as treatment quality, innovation, regulatory compliance, customer service, and pricing strategies.
 

Saliva Collection and Diagnostics Market Companies

Prominent players operating in the market industry include:

• Abbott Laboratories
• Akonni Biosystems, Inc.
• Autogen, Inc.
• Meridian Bioscience, Inc.
• Neogen Inc
• Norgen Biotek Corp
• OraSure Technologies, Inc
• Porex
• Salimetrics, LLC.
• Sarstedt AG & Co.KG
• Spectrum Solutions, LLC.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• Wuxi NEST Biotechnology Co., Ltd
• ZRT Laboratory
• Zymo Research Corporation
   

Saliva Collection and Diagnostics Industry News:

• In February 2024, the NHS launched a national BRCA gene testing campaign aimed at early cancer detection. This initiative plans to utilize a simple genetic saliva test, highlighting the effectiveness and ease of saliva-based diagnostics for identifying cancer risk.  
   
• In January 2024, SalivaTech announced the launch of its innovative saliva test for cancer detection, further advancing the use of non-invasive diagnostic methods in oncology.
   

The saliva collection and diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Site of Collection

• Parotid gland
• Submandibular/Sublingual gland
• Minor salivary glands

Market, By Application

• Disease diagnostics
  • Infectious diseases
  • Genetic testing
  • Other disease diagnostics 
• Forensics
• Research

Market, By End-use

• Hospitals and dental clinics
• Diagnostic laboratories
• Pharmaceutical & biotechnology companies
• Research Institutes
• Forensic laboratories

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa